Optimizing Medical Management of Uterine Fibroids
Discover how you can individualize the management of uterine fibroids and more fully include your patients in decisions about their care.
Available credits: 1.00
Time to complete: 60 minutes
Released:
Valid until:
If you’ve already completed the activity.
In this activity, Drs. Bradley and Singh and Ms. Venable discuss methods for ensuring an early diagnosis of uterine fibroids, strategies for shared decision-making with patients, and current evidence about medical options throughout the patient journey. Join us to make sure you’re putting the focus where it needs to be—on the individual goals and preferences of your patients.
This was a live broadcast, the Q&A portion is no longer available for this program.
In accordance with the ACCME Standards for Commercial Support, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. GLC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.
Host:
Linda D. Bradley, MD
Professor, Obstetrics and Gynecology and Reproductive Biology
Cleveland Clinic
Cleveland, OH
No relevant relationship reported
Faculty:
Sukhbir Sony Singh, MD
Professor, Department of Obstetrics & Gynecology
The Ottawa Hospital/University of Ottawa
Associate Scientist and the Dr. E. Jolly Research Chair in Gynecologic Surgery
The Ottawa Hospital Research Institute
Ottawa, ON Canada
Consulting Fees & Speaker Bureau: AbbVie
Sateria Venable
Founder & CEO of The Fibroid Foundation
Bethesda, MD
Consulting Fees: AbbVie
Reviewers/Content Planners/Authors:
After participating in this educational activity, participants should be better able to:
This activity is designed to meet the educational needs of obstetricians, gynecologists, family physicians, nurse practitioners, and physician assistants.
Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Global Learning Collaborative designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Omnia Education is the leading provider of education for women’s health professionals. Our activities are recognized nationwide for providing credible, relevant, and practical information on issues impacting the female patient. Additionally, our unique focus has transformed the CME learning environment, and our ability to help learners recognize and overcome barriers to optimal performance and optimal patient outcomes has positioned us as a leader in women’s health education.
This activity is supported by an independent educational grant from AbbVie.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Omnia Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Omnia Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.
Reproduction Prohibited
Reproduction of this material is not permitted without written permission from the copyright owner.
A New Nonhormonal Contraceptive Choice: The Vaginal pH Modulator
Facebook Comments